期刊文献+

天疱疮主要自身抗体及其检测临床意义研究进展 被引量:1

Major autoantibodies in pemphigus:detection and clinical significance
下载PDF
导出
摘要 天疱疮是一种严重的自身免疫性疾病,主要损害皮肤及黏膜的屏障功能。该病是由患者体内产生的针对细胞间黏附分子等结构的自身抗体导致,其中主要产生致病作用的抗体是针对桥粒芯蛋白(desmogelin,Dsg)1和Dsg3的抗体。这2种抗体主要通过空间位阻效应及抗原抗体结合之后的信号转导两方面机制致病,而抗Dsc抗体、抗斑蛋白家族抗体、抗乙酰胆碱受体抗体等也在致病过程中起着重要的协同作用。随着免疫荧光、酶联免疫吸附试验(enzyme-linked immunosorbent assays,ELISA)等技术的普及,抗体检测已成为天疱疮临床诊断、病程监测的重要方法。新近临床研究提示,抗Dsg1、Dsg3抗体滴度与天疱疮病情活动程度间存在相关性,同时可监测病情的复发及指导临床用药。 Pemphigus is a severe autoimmune disease causing damage of epidermis and mucosa. Patients can pro-duce autoantibodies against structures like intercellular adhesion, which leads to disease. Main pathogenic antibodies in-clude anti-Gsg1 and anti-Gsg3 which cause disease primarily through steric hindrance and signal transduction after antigen-antibody binding. Other antibodies such as anti-Dsc, anti-plakin family, anti-acetylcholine receptor etc. also play an important synergistic effect in the pathogenic process. With the popularization of immunofluorescence, ELISA and other technologies, antibody detection has become an important method for clinical diagnosis and monitoring of pemphigus. Cou-ples of clinical studies have shown that the titers of anti-Dsg1 and Dsg3 antibodies are related to the activity of pemphigus disease, which can also indicate the recurrence of the disease and guide clinical medication. More mechanism research and clinical exploration of pemphigus autoantibodies will help us to cognize the disease further.
作者 王麒钧 朱海琴 潘萌 WANG Qijun;ZHU Haiqin;PAN Meng(Department of Dermaologr,Ruijin Hospital,Shanghai Joo Tong University School of Medicine,Shanghai 200025,China)
出处 《诊断学理论与实践》 2022年第5期638-643,共6页 Journal of Diagnostics Concepts & Practice
基金 国家自然科学基金项目(82173407,81730085,81773321)。
关键词 天疱疮 自身抗体 桥粒芯蛋白 疗效监测 Pemphigus Autoantibody Desmogelin Efficacy monitoring
  • 相关文献

参考文献5

二级参考文献32

  • 1李晓东,赵玉铭,王雅坤,肖毅,陈洪铎.天疱疮患者头发毛囊与皮损中自身抗体沉积的比较[J].中国皮肤性病学杂志,2005,19(4):196-197. 被引量:3
  • 2Sitaru C,Zillikens D.Mechanisms of blister induction by autoantibodies.Exp Dermatol,2005,14(12):861-875.
  • 3Cheng SW,Amagai M,Nishikawa T,et al.Monitoring disease activity in pemphigus with enzyme-linked immunosorbent assay using recombinant desmogleins 1 and 3.Br J Dermatol,2002,147(2):261-265.
  • 4Kwon EJ,Yamagami J,Nishikawa T,et al.Anti-desmoglein IgG autoantibodies in patients with pemphigus in remission.J Eur Acad Dermatol Venereol,2008,22(9):1070-1075.
  • 5Pfütze M,Niedermeier A,Hertl M,et al.Introducing a novel Autoimmune Bullous Skin Disorder Intensity Score (ABSIS) in pemphigus.Eur J Dermatol,2007,17 (1):4-11.
  • 6Amagai M,Tsunoda K,Zillikens D,et al.The clinical phenotype of pemphigus is defined by the anti-desmoglein anto-antibody profile.J Am Acad Dermatol,1999,40(2 Pt 1):167-170.
  • 7Daneshpazhooh M,Chams-Davatchi C,Khamesipour A.Desmoglein 1 and 3 enzyme-linked immunosorbent assay in Iranian patients with pemphigus vulgaris:correlation with phenotype,severity,and disease activity.J Eur Acad Dermatol Venereol,2007,21(10):1319-1324.
  • 8Hashimoto T.Recent advances in the study of the pathophysiology of pemphigus.Arch Dermatol Res,2003,295 Suppl 1:S2-11.
  • 9Futei Y,Amagai M,Ishii K,et al.Predominant IgG4 subclass in autoantibodies of pemphigus vulgaris and foliaceus.J Dermatol Sci,2001,26(1):55-61.
  • 10Green MG,Bystryn JC.Effect of Intravenous immunoglobulin therapy on serum levels of IgG1 and IgG4 antidesmoglein 1 and antidesmoglein 3 antibodies in pemphigus vulgaris.Arch Dermatol,2008,144(12):1621-1624.

共引文献8

同被引文献15

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部